Physician profile
Danielle Harris
NPI 1497119648
$824.35
in general payments reported to CMS, 2019-2025
21 companies · $15.01 in 2025
The $15.01 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $31.51 · 2021: $213 · 2022: $106 · 2023: $103 · 2024: $29.84 · 2025: $15.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $149.64 | 2019 | |
| Amarin Pharma, INC. | $103.26 | 2019 | |
| Sanofi Pasteur INC. | $71.18 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.88 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $42.53 | 2023-2024 | Quviviq |
| Lilly USA, LLC | $41.27 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.40 | 2022 | |
| Abbvie INC. | $34.87 | 2021 | |
| Amgen INC. | $33.57 | 2019 | |
| Glaxosmithkline, LLC. | $31.51 | 2020 | |
| Janssen Pharmaceuticals, INC | $28.28 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $27.66 | 2021 | |
| Abbott Laboratories | $24.68 | 2023 | Freestyle Libre 3 |
| Lundbeck LLC | $21.17 | 2023 | Rexulti |
| Exeltis, USA INC. | $18.92 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.39 | 2021 | |
| Medline Industries LP | $15.01 | 2025 | |
| Cranial Technologies, INC | $15.00 | 2019 | |
| Glenmark Therapeutics INC. | $13.00 | 2019 | |
| Pfizer INC. | $12.57 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.